nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—F2—vein—intracranial aneurysm	0.0804	0.192	CbGeAlD
Suramin—ARSA—Glycosphingolipid metabolism—ASAH1—intracranial aneurysm	0.0708	0.122	CbGpPWpGaD
Suramin—F2—IL1 and megakaryotyces in obesity—TIMP2—intracranial aneurysm	0.0487	0.0838	CbGpPWpGaD
Suramin—ARSA—Sphingolipid metabolism—ASAH1—intracranial aneurysm	0.0439	0.0755	CbGpPWpGaD
Suramin—SIRT1—E2F transcription factor network—RBBP8—intracranial aneurysm	0.0365	0.0628	CbGpPWpGaD
Suramin—F2—artery—intracranial aneurysm	0.0328	0.0782	CbGeAlD
Suramin—FSHR—cerebellum—intracranial aneurysm	0.0239	0.057	CbGeAlD
Suramin—FSHR—Peptide GPCRs—EDNRA—intracranial aneurysm	0.0226	0.0389	CbGpPWpGaD
Suramin—SIRT5—medulla oblongata—intracranial aneurysm	0.0222	0.053	CbGeAlD
Suramin—P2RX4—medulla oblongata—intracranial aneurysm	0.021	0.0501	CbGeAlD
Suramin—FSHR—GPCRs, Other—EDNRA—intracranial aneurysm	0.0192	0.033	CbGpPWpGaD
Suramin—SIRT1—medulla oblongata—intracranial aneurysm	0.0184	0.0439	CbGeAlD
Suramin—RYR1—medulla oblongata—intracranial aneurysm	0.017	0.0406	CbGeAlD
Suramin—SIRT1—midbrain—intracranial aneurysm	0.0168	0.0401	CbGeAlD
Suramin—F2—IL1 and megakaryotyces in obesity—TIMP1—intracranial aneurysm	0.0161	0.0276	CbGpPWpGaD
Suramin—SIRT5—cerebellum—intracranial aneurysm	0.0157	0.0375	CbGeAlD
Suramin—RYR1—midbrain—intracranial aneurysm	0.0155	0.0371	CbGeAlD
Suramin—P2RX4—cerebellum—intracranial aneurysm	0.0149	0.0354	CbGeAlD
Suramin—SIRT1—cerebellum—intracranial aneurysm	0.013	0.031	CbGeAlD
Suramin—ARSA—cerebellum—intracranial aneurysm	0.0129	0.0307	CbGeAlD
Suramin—SIRT5—brain—intracranial aneurysm	0.0128	0.0304	CbGeAlD
Suramin—PLA2G4A—Prostaglandin Synthesis and Regulation—EDNRA—intracranial aneurysm	0.0126	0.0217	CbGpPWpGaD
Suramin—P2RX4—brain—intracranial aneurysm	0.0121	0.0288	CbGeAlD
Suramin—RYR1—cerebellum—intracranial aneurysm	0.012	0.0287	CbGeAlD
Suramin—PLA2G2A—midbrain—intracranial aneurysm	0.0118	0.0281	CbGeAlD
Suramin—P2RY2—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.0112	0.0192	CbGpPWpGaD
Suramin—SIRT1—brain—intracranial aneurysm	0.0106	0.0252	CbGeAlD
Suramin—ARSA—brain—intracranial aneurysm	0.0104	0.0249	CbGeAlD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.0103	0.0178	CbGpPWpGaD
Suramin—P2RY2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.00998	0.0172	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—CST3—intracranial aneurysm	0.0099	0.017	CbGpPWpGaD
Suramin—RYR1—brain—intracranial aneurysm	0.00977	0.0233	CbGeAlD
Suramin—PLA2G4A—medulla oblongata—intracranial aneurysm	0.00896	0.0214	CbGeAlD
Suramin—P2RY2—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00862	0.0148	CbGpPWpGaD
Suramin—F2—Regulation of IGF Activity by IGFBP—MMP2—intracranial aneurysm	0.00859	0.0148	CbGpPWpGaD
Suramin—FSHR—GPCRs, Class A Rhodopsin-like—EDNRA—intracranial aneurysm	0.00833	0.0143	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.0083	0.0143	CbGpPWpGaD
Suramin—PLA2G4A—midbrain—intracranial aneurysm	0.00819	0.0195	CbGeAlD
Suramin—F2—IL1 and megakaryotyces in obesity—CCL2—intracranial aneurysm	0.00812	0.014	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—STARD13—intracranial aneurysm	0.00782	0.0135	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—STARD13—intracranial aneurysm	0.00755	0.013	CbGpPWpGaD
Suramin—PLA2G2A—brain—intracranial aneurysm	0.0074	0.0177	CbGeAlD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00739	0.0127	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00714	0.0123	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—NCF1—intracranial aneurysm	0.0071	0.0122	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—EDNRA—intracranial aneurysm	0.00696	0.012	CbGpPWpGaD
Suramin—F2—IL1 and megakaryotyces in obesity—MMP9—intracranial aneurysm	0.0058	0.00999	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00563	0.00969	CbGpPWpGaD
Suramin—F2—brain—intracranial aneurysm	0.00559	0.0133	CbGeAlD
Suramin—ARSA—Metabolism—SLC25A16—intracranial aneurysm	0.00558	0.00961	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00543	0.00935	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00535	0.00921	CbGpPWpGaD
Suramin—PLA2G4A—brain—intracranial aneurysm	0.00515	0.0123	CbGeAlD
Suramin—RYR1—Myometrial Relaxation and Contraction Pathways—NOS3—intracranial aneurysm	0.00503	0.00866	CbGpPWpGaD
Suramin—F2—Syndecan-4-mediated signaling events—MMP9—intracranial aneurysm	0.00461	0.00794	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—AGER—intracranial aneurysm	0.00461	0.00793	CbGpPWpGaD
Suramin—F2—PAR1-mediated thrombin signaling events—NOS3—intracranial aneurysm	0.00454	0.00781	CbGpPWpGaD
Suramin—F2—Vitamin B12 Metabolism—CCL2—intracranial aneurysm	0.00444	0.00765	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—CCL2—intracranial aneurysm	0.00441	0.00759	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—intracranial aneurysm	0.00429	0.00739	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—NOS3—intracranial aneurysm	0.00402	0.00692	CbGpPWpGaD
Suramin—ARSA—Metabolism—ASAH1—intracranial aneurysm	0.0037	0.00636	CbGpPWpGaD
Suramin—P2RY2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00364	0.00627	CbGpPWpGaD
Suramin—F2—Folate Metabolism—CCL2—intracranial aneurysm	0.00361	0.00622	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—SLC25A16—intracranial aneurysm	0.0036	0.00619	CbGpPWpGaD
Suramin—FSHR—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00352	0.00605	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CST3—intracranial aneurysm	0.00349	0.00601	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—EDNRA—intracranial aneurysm	0.00319	0.00549	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00318	0.00547	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—MMP9—intracranial aneurysm	0.00315	0.00543	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—EDNRA—intracranial aneurysm	0.00315	0.00542	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP2—intracranial aneurysm	0.00314	0.00541	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.00307	0.00529	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—NOS3—intracranial aneurysm	0.00295	0.00507	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00289	0.00497	CbGpPWpGaD
Suramin—F2—Selenium Micronutrient Network—CCL2—intracranial aneurysm	0.00287	0.00494	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—intracranial aneurysm	0.00285	0.00491	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EDNRA—intracranial aneurysm	0.00279	0.0048	CbGpPWpGaD
Suramin—P2RY2—GPCR ligand binding—CCL2—intracranial aneurysm	0.00277	0.00477	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00272	0.00468	CbGpPWpGaD
Suramin—FSHR—GPCR ligand binding—CCL2—intracranial aneurysm	0.00268	0.00461	CbGpPWpGaD
Suramin—PLA2G4A—Platelet homeostasis—NOS3—intracranial aneurysm	0.00258	0.00444	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—ASAH1—intracranial aneurysm	0.00252	0.00434	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TIMP1—intracranial aneurysm	0.00249	0.00428	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ASAH1—intracranial aneurysm	0.00238	0.0041	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—MMP9—intracranial aneurysm	0.00236	0.00407	CbGpPWpGaD
Suramin—F2—Signaling Pathways—STARD13—intracranial aneurysm	0.00223	0.00385	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—EDNRA—intracranial aneurysm	0.00211	0.00363	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—STARD13—intracranial aneurysm	0.00204	0.00352	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NCF1—intracranial aneurysm	0.00181	0.00311	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NCF1—intracranial aneurysm	0.00174	0.003	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EDNRA—intracranial aneurysm	0.00171	0.00294	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—SLC25A16—intracranial aneurysm	0.00169	0.00292	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—CCL2—intracranial aneurysm	0.00168	0.00289	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EDNRA—intracranial aneurysm	0.00165	0.00284	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—EDNRA—intracranial aneurysm	0.00161	0.00277	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—MMP2—intracranial aneurysm	0.0016	0.00275	CbGpPWpGaD
Suramin—F2—Peptide ligand-binding receptors—CCL2—intracranial aneurysm	0.00155	0.00267	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—CCL2—intracranial aneurysm	0.00142	0.00245	CbGpPWpGaD
Suramin—F2—Hemostasis—TIMP1—intracranial aneurysm	0.0014	0.00241	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—CCL2—intracranial aneurysm	0.00137	0.00237	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TIMP1—intracranial aneurysm	0.00128	0.00221	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ASAH1—intracranial aneurysm	0.00112	0.00193	CbGpPWpGaD
Suramin—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—intracranial aneurysm	0.00104	0.00179	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—EDNRA—intracranial aneurysm	0.000908	0.00156	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCL2—intracranial aneurysm	0.00084	0.00145	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000825	0.00142	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCL2—intracranial aneurysm	0.000812	0.0014	CbGpPWpGaD
Suramin—F2—GPCR ligand binding—CCL2—intracranial aneurysm	0.000792	0.00136	CbGpPWpGaD
Suramin—ARSA—Metabolism—NOS3—intracranial aneurysm	0.000771	0.00133	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EDNRA—intracranial aneurysm	0.000755	0.0013	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NOS3—intracranial aneurysm	0.000749	0.00129	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NOS3—intracranial aneurysm	0.000723	0.00125	CbGpPWpGaD
Suramin—F2—Hemostasis—NOS3—intracranial aneurysm	0.000631	0.00109	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MMP9—intracranial aneurysm	0.000601	0.00103	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MMP9—intracranial aneurysm	0.00058	0.000999	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NOS3—intracranial aneurysm	0.000577	0.000994	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CCL2—intracranial aneurysm	0.000557	0.000959	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MMP2—intracranial aneurysm	0.00053	0.000913	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NCF1—intracranial aneurysm	0.000516	0.000888	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—NOS3—intracranial aneurysm	0.000497	0.000855	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EDNRA—intracranial aneurysm	0.000487	0.000839	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NCF1—intracranial aneurysm	0.000472	0.000813	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EDNRA—intracranial aneurysm	0.000446	0.000767	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—CCL2—intracranial aneurysm	0.000407	0.0007	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—CCL2—intracranial aneurysm	0.000372	0.00064	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCL2—intracranial aneurysm	0.00024	0.000413	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—NOS3—intracranial aneurysm	0.000234	0.000403	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCL2—intracranial aneurysm	0.00022	0.000378	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NOS3—intracranial aneurysm	0.000214	0.000369	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NOS3—intracranial aneurysm	0.000196	0.000337	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MMP9—intracranial aneurysm	0.000172	0.000296	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MMP9—intracranial aneurysm	0.000157	0.00027	CbGpPWpGaD
